-
2
-
-
28044445881
-
Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells
-
doi: 10.1186/1465-9921-6-135
-
Chan, M. C., et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6, 135, doi: 10.1186/1465-9921-6-135 (2005).
-
(2005)
Respir Res
, vol.6
, pp. 135
-
-
Chan, M.C.1
-
3
-
-
33749511112
-
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
-
doi: 10.1038/nm1477
-
de Jong, M. D., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12, 1203-1207, doi: 10.1038/nm1477 (2006).
-
(2006)
Nat Med
, vol.12
, pp. 1203-1207
-
-
De Jong, M.D.1
-
4
-
-
84927919568
-
Genesis of avian influenza H9N2 in Bangladesh
-
doi: 10.1038/emi.2014.84
-
Shanmuganatham, K., et al. Genesis of avian influenza H9N2 in Bangladesh. Emerg Microbes Infect 3, e88, doi: 10.1038/emi.2014.84 (2014).
-
(2014)
Emerg Microbes Infect
, vol.3
, pp. e88
-
-
Shanmuganatham, K.1
-
5
-
-
84933579614
-
Differences in the epidemiology of human cases of avian influenza a(h7n9) and a(h5n1) viruses infection
-
doi: 10.1093/cid/civ345
-
Qin, Y., et al. Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection. Clin Infect Dis, doi: 10.1093/cid/civ345 (2015).
-
(2015)
Clin Infect Dis
-
-
Qin, Y.1
-
6
-
-
84911979789
-
A novel highly pathogenic H5N8 avian influenza virus isolated from a wild duck in China
-
doi: 10.1111/irv.12289
-
Fan, S., et al. A novel highly pathogenic H5N8 avian influenza virus isolated from a wild duck in China. Influenza Other Respir Viruses 8, 646-653, doi: 10.1111/irv.12289 (2014).
-
(2014)
Influenza Other Respir Viruses
, vol.8
, pp. 646-653
-
-
Fan, S.1
-
7
-
-
84929591129
-
Intercontinental spread of asian-origin h5n8 to North America through beringia by migratory birds
-
doi: 10.1128/JVI.00728-15
-
Lee, D. H., et al. Intercontinental Spread of Asian-Origin H5N8 to North America through Beringia by Migratory Birds. J Virol 89, 6521-6524, doi: 10.1128/JVI.00728-15 (2015).
-
(2015)
J Virol
, vol.89
, pp. 6521-6524
-
-
Lee, D.H.1
-
8
-
-
84922326721
-
Heterologous prime-boost vaccination using an AS03B-Adjuvanted influenza A(H5N1) vaccine in infants and children < 3 years of age
-
doi: 10.1093/infdis/jiu359
-
Nolan, T., et al. Heterologous prime-boost vaccination using an AS03B-Adjuvanted influenza A(H5N1) vaccine in infants and children
-
(2014)
The Journal of Infectious Diseases
, vol.210
, pp. 1800-1810
-
-
Nolan, T.1
-
9
-
-
77954632352
-
-
News releaseAvailable at (Accessed: 9th March2016
-
U.S. Food and Drug Administration. News release (2013). Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm376444.htm (Accessed: 9th March 2016).
-
(2013)
US Food and Drug Administration
-
-
-
11
-
-
84922726229
-
Antiviral combinations for severe influenza
-
doi: 10.1016/S1473-3099(14)70821-7
-
Dunning, J., et al. Antiviral combinations for severe influenza. The Lancet. Infectious diseases 14, 1259-1270, doi: 10.1016/S1473-3099(14)70821-7 (2014).
-
(2014)
The Lancet. Infectious Diseases
, vol.14
, pp. 1259-1270
-
-
Dunning, J.1
-
12
-
-
84904746307
-
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-Therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial
-
doi: 10.1016/S1473-3099(14)70736-4
-
Cahn, P., et al. Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-Therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial. The Lancet. Infectious diseases 14, 572-580, doi: 10.1016/S1473-3099(14)70736-4 (2014).
-
(2014)
The Lancet. Infectious Diseases
, vol.14
, pp. 572-580
-
-
Cahn, P.1
-
13
-
-
21244447705
-
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
-
doi: 10.1056/NEJMoa043470
-
Lau, G K., et Al. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-positive Chronic Hepatitis B. the New England Journal of Medicine 352, 2682-2695, Doi: 10.1056/NEJMoa043470 (2005).
-
(2005)
The New England journal of medicine
, vol.352
, pp. 2682-2695
-
-
Lau, G.K.1
-
14
-
-
84929513365
-
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: An open-label, randomised, phase 3 trial
-
doi: 10.1016/S1473-3099(15)70099-X
-
Mizokami, M., et al. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. The Lancet. Infectious diseases 15, 645-653, doi: 10.1016/S1473-3099(15)70099-X (2015).
-
(2015)
The Lancet. Infectious Diseases
, vol.15
, pp. 645-653
-
-
Mizokami, M.1
-
15
-
-
78650232558
-
Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model
-
doi: 10.1016/j.antiviral.2010.09.020
-
Bantia, S., Kellogg, D., Parker, C. D., & Babu, Y. S. Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model. Antiviral Res 88, 276-280, doi: 10.1016/j.antiviral.2010.09.020 (2010).
-
(2010)
Antiviral Res
, vol.88
, pp. 276-280
-
-
Bantia, S.1
Kellogg, D.2
Parker, C.D.3
Babu, Y.S.4
-
16
-
-
9644262504
-
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells
-
doi: 10.1128/AAC.48.12.4855-4863.2004
-
Govorkova, E. A., Fang, H. B., Tan, M., & Webster, R. G. Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrobial agents and chemotherapy 48, 4855-4863, doi: 10.1128/AAC.48.12.4855-4863.2004 (2004).
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, pp. 4855-4863
-
-
Govorkova, E.A.1
Fang, H.B.2
Tan, M.3
Webster, R.G.4
-
17
-
-
34249001427
-
Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice
-
Ilyushina, N. A., Hoffmann, E., Salomon, R., Webster, R. G., & Govorkova, E. A. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice. Antivir Ther 12, 363-370 (2007).
-
(2007)
Antivir Ther
, vol.12
, pp. 363-370
-
-
Ilyushina, N.A.1
Hoffmann, E.2
Salomon, R.3
Webster, R.G.4
Govorkova, E.A.5
-
18
-
-
0028932874
-
In vitro inhibitory effects of combinations of anti-influenza agents
-
Madren, L. K., Shipman, Jr. C., & Hayden, F. G. In vitro inhibitory effects of combinations of anti-influenza agents. Antiviral Chemistry & Chemotherapy 2, 109-113 (1995).
-
(1995)
Antiviral Chemistry & Chemotherapy
, vol.2
, pp. 109-113
-
-
Madren, L.K.1
Shipman, C.2
Hayden, F.G.3
-
19
-
-
0042656406
-
Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza
-
Ison, M. G., et al. Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. Antivir Ther 8, 183-190 (2003).
-
(2003)
Antivir Ther
, vol.8
, pp. 183-190
-
-
Ison, M.G.1
-
21
-
-
76249125006
-
T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
-
doi: 10.1073/pnas.0909603107
-
Kiso, M., et al. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proc Natl Acad Sci USA 107, 882-887, doi: 10.1073/pnas.0909603107 (2010).
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 882-887
-
-
Kiso, M.1
-
22
-
-
84885660826
-
Characterization of H7N9 influenza A viruses isolated from humans
-
doi: 10.1038/nature12392
-
Watanabe, T., et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501, 551-555, doi: 10.1038/nature12392 (2013).
-
(2013)
Nature
, vol.501
, pp. 551-555
-
-
Watanabe, T.1
-
23
-
-
73849083795
-
Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice
-
doi: 10.1128/AAC.00933-09
-
Smee, D. F., et al. Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice. Antimicrobial agents and chemotherapy 54, 126-133, doi: 10.1128/AAC.00933-09 (2010).
-
(2010)
Antimicrobial Agents and Chemotherapy
, vol.54
, pp. 126-133
-
-
Smee, D.F.1
-
25
-
-
84885448756
-
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
-
doi: 10.1016/j. antiviral.2013.09.015
-
Furuta, Y., et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res 100, 446-454, doi: 10.1016/j. antiviral.2013.09.015 (2013).
-
(2013)
Antiviral Res
, vol.100
, pp. 446-454
-
-
Furuta, Y.1
-
26
-
-
68849100983
-
Severe respiratory disease concurrent with the circulation of H1N1 influenza
-
doi: 10.1056/NEJMoa0904023
-
Chowell, G., et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. The New England journal of medicine 361, 674-679, doi: 10.1056/NEJMoa0904023 (2009).
-
(2009)
The New England Journal of Medicine
, vol.361
, pp. 674-679
-
-
Chowell, G.1
-
27
-
-
50149111585
-
Factors associated with case fatality of human H5N1 virus infections in Indonesia: A case series
-
doi: 10.1016/S0140-6736(08)61125-3
-
Kandun, I. N., et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 372, 744-749, doi: 10.1016/S0140-6736(08)61125-3 (2008).
-
(2008)
Lancet
, vol.372
, pp. 744-749
-
-
Kandun, I.N.1
-
28
-
-
69149095237
-
Viral loads and duration of viral shedding in adult patients hospitalized with influenza
-
doi: 10.1086/600383
-
Lee, N., et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. The Journal of infectious diseases 200, 492-500, doi: 10.1086/600383 (2009).
-
(2009)
The Journal of Infectious Diseases
, vol.200
, pp. 492-500
-
-
Lee, N.1
-
29
-
-
68149107226
-
Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico
-
doi: 10.1056/NEJMoa0904252
-
Perez-Padilla, R., et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. The New England journal of medicine 361, 680-689, doi: 10.1056/NEJMoa0904252 (2009).
-
(2009)
The New England Journal of Medicine
, vol.361
, pp. 680-689
-
-
Perez-Padilla, R.1
-
30
-
-
38349068756
-
Update on avian influenza A (H5N1) virus infection in humans
-
Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza, A. V., et al. doi: 10.1056/NEJMra0707279
-
Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza, A. V., et al. Update on avian influenza A (H5N1) virus infection in humans. The New England journal of medicine 358, 261-273, doi: 10.1056/NEJMra0707279 (2008).
-
(2008)
The New England Journal of Medicine
, vol.358
, pp. 261-273
-
-
-
31
-
-
77954981636
-
Competitive fitness of oseltamivir-sensitive and-resistant highly pathogenic H5N1 influenza viruses in a ferret model
-
doi: 10.1128/JVI.00689-10
-
Govorkova, E. A., Ilyushina, N. A., Marathe, B. M., McClaren, J. L., & Webster, R. G. Competitive fitness of oseltamivir-sensitive and-resistant highly pathogenic H5N1 influenza viruses in a ferret model. J Virol 84, 8042-8050, doi: 10.1128/JVI.00689-10 (2010).
-
(2010)
J Virol
, vol.84
, pp. 8042-8050
-
-
Govorkova, E.A.1
Ilyushina, N.A.2
Marathe, B.M.3
McClaren, J.L.4
Webster, R.G.5
-
32
-
-
84875107202
-
T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro
-
doi: 10.1128/JVI.02346-12
-
Baranovich, T., et al. T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro. J Virol 87, 3741-3751, doi: 10.1128/JVI.02346-12 (2013).
-
(2013)
J Virol
, vol.87
, pp. 3741-3751
-
-
Baranovich, T.1
-
33
-
-
70349272201
-
Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses
-
doi: 10.1128/JVI.01109-09
-
Zhou, B., et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol 83, 10309-10313, doi: 10.1128/JVI.01109-09 (2009).
-
(2009)
J Virol
, vol.83
, pp. 10309-10313
-
-
Zhou, B.1
-
34
-
-
84929999966
-
Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection
-
doi: 10.1128/mBio.02464-14
-
Rogers, M. B., et al. Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection. MBio 6, doi: 10.1128/mBio.02464-14 (2015).
-
(2015)
MBio
, vol.6
-
-
Rogers, M.B.1
-
35
-
-
84926647098
-
Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck
-
doi: 10.1038/ncomms7553
-
Zaraket, H., et al. Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck. Nat Commun 6, 6553, doi: 10.1038/ncomms7553 (2015).
-
(2015)
Nat Commun
, vol.6
, pp. 6553
-
-
Zaraket, H.1
-
36
-
-
84921260778
-
Similar prevalence of low-Abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing. PloS one 9, e105569
-
doi: 10.1371/0105569
-
Margeridon-Thermet, S., et al. Similar prevalence of low-Abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing. PloS one 9, e105569, doi: 10.1371/journal.pone.0105569 (2014).
-
(2014)
Journal.pone.
-
-
Margeridon-Thermet, S.1
-
37
-
-
84859878103
-
Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing
-
doi: 10.1371/journal.pone.0035052
-
Nishijima, N., et al. Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing. PloS one 7, e35052, doi: 10.1371/journal.pone.0035052 (2012).
-
(2012)
PloS One
, vol.7
, pp. e35052
-
-
Nishijima, N.1
-
38
-
-
84875994350
-
A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model
-
doi: 10.1016/j.antiviral.2013.03.007
-
Ramirez, C., et al. A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a model. Antiviral Res 98, 273-283, doi: 10.1016/j.antiviral.2013.03.007 (2013).
-
(2013)
Antiviral Res
, vol.98
, pp. 273-283
-
-
Ramirez, C.1
-
39
-
-
84885907998
-
Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase
-
doi: 10.1128/AAC.00649-13
-
Sangawa, H., et al. Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase. Antimicrobial agents and chemotherapy 57, 5202-5208, doi: 10.1128/AAC.00649-13 (2013).
-
(2013)
Antimicrobial Agents and Chemotherapy
, vol.57
, pp. 5202-5208
-
-
Sangawa, H.1
-
40
-
-
14744274674
-
Mechanism of action of T-705 against influenza virus
-
doi: 10.1128/AAC.49.3.981-986.2005
-
Furuta, Y., et al. Mechanism of action of T-705 against influenza virus. Antimicrobial agents and chemotherapy 49, 981-986, doi: 10.1128/AAC.49.3.981-986.2005 (2005).
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, pp. 981-986
-
-
Furuta, Y.1
-
41
-
-
25444501243
-
Neuraminidase inhibitors for influenza
-
doi: 10.1056/NEJMra050740
-
Moscona, A. Neuraminidase inhibitors for influenza. The New England journal of medicine 353, 1363-1373, doi: 10.1056/NEJMra050740 (2005).
-
(2005)
The New England Journal of Medicine
, vol.353
, pp. 1363-1373
-
-
Moscona, A.1
-
42
-
-
79251559935
-
Combination chemotherapy for influenza
-
doi: 10.3390/v2081510
-
Govorkova, E. A., & Webster, R. G. Combination chemotherapy for influenza. Viruses 2, 1510-1529, doi: 10.3390/v2081510 (2010).
-
(2010)
Viruses
, vol.2
, pp. 1510-1529
-
-
Govorkova, E.A.1
Webster, R.G.2
-
43
-
-
55849102109
-
Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice
-
doi: 10.1128/AAC.01579-07
-
Ilyushina, N. A., et al. Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrobial agents and chemotherapy 52, 3889-3897, doi: 10.1128/AAC.01579-07 (2008).
-
(2008)
Antimicrobial Agents and Chemotherapy
, vol.52
, pp. 3889-3897
-
-
Ilyushina, N.A.1
-
44
-
-
84886683780
-
Synergistic combinations of favipiravir and oseltamivir against wild-Type pandemic and oseltamivir-resistant influenza A virus infections in mice
-
doi: 10.2217/fvl.13.98
-
Smee, D. F., Tarbet, E. B., Furuta, Y., Morrey, J. D., & Barnard, D. L. Synergistic combinations of favipiravir and oseltamivir against wild-Type pandemic and oseltamivir-resistant influenza A virus infections in mice. Future Virol 8, 1085-1094, doi: 10.2217/fvl.13.98 (2013).
-
(2013)
Future Virol
, vol.8
, pp. 1085-1094
-
-
Smee, D.F.1
Tarbet, E.B.2
Furuta, Y.3
Morrey, J.D.4
Barnard, D.L.5
-
45
-
-
84901975118
-
In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus
-
doi: 10.1007/s00705-013-1922-1
-
Tarbet, E. B., et al. In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus. Arch Virol 159, 1279-1291, doi: 10.1007/s00705-013-1922-1 (2014).
-
(2014)
Arch Virol
, vol.159
, pp. 1279-1291
-
-
Tarbet, E.B.1
-
46
-
-
33847688459
-
Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice
-
doi: 10.1128/AAC.01051-06
-
Sidwell, R. W., et al. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrobial agents and chemotherapy 51, 845-851, doi: 10.1128/AAC.01051-06 (2007).
-
(2007)
Antimicrobial Agents and Chemotherapy
, vol.51
, pp. 845-851
-
-
Sidwell, R.W.1
-
47
-
-
84859053626
-
Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice
-
doi: 10.1016/j.antiviral.2012.03.001
-
Tarbet, E. B., et al. Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice. Antiviral Res 94, 103-110, doi: 10.1016/j.antiviral.2012.03.001 (2012).
-
(2012)
Antiviral Res
, vol.94
, pp. 103-110
-
-
Tarbet, E.B.1
-
48
-
-
77955985167
-
A systematic review of side effects of nucleoside and nucleotide drugs used for treatment of chronic hepatitis B
-
doi: 10.1007/s11901-010-0039-1
-
Khungar, V., & Han, S H. A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B. Curr Hepat Rep 9, 75-90, Doi: 10.1007/s11901-010-0039-1 (2010).
-
(2010)
Curr Hepat Rep
, vol.9
, pp. 75-90
-
-
Khungar, V.1
Han, S.H.2
-
49
-
-
66149190942
-
Side effects of long-Term oral antiviral therapy for hepatitis B
-
doi: 10.1002/hep.22885
-
Fontana, R. J. Side effects of long-Term oral antiviral therapy for hepatitis B. Hepatology 49, S185-195, doi: 10.1002/hep.22885 (2009).
-
(2009)
Hepatology
, vol.49
, pp. S185-S195
-
-
Fontana, R.J.1
-
50
-
-
70449854577
-
Innate immune responses to influenza A H5N1: Friend or foe?
-
doi: 10.1016/j.it.2009.09.004
-
Peiris, J S., Cheung, C. Y., Leung, C. Y., & Nicholls, J. M. Innate immune responses to influenza A H5N1: friend or foe?. Trends Immunol 30, 574-584, doi: 10.1016/j.it.2009.09.004 (2009).
-
(2009)
Trends Immunol
, vol.30
, pp. 574-584
-
-
Peiris, J.S.1
Cheung, C.Y.2
Leung, C.Y.3
Nicholls, J.M.4
-
51
-
-
10744231351
-
Re-emergence of fatal human influenza A subtype H5N1 disease
-
doi: 10.1016/S0140-6736(04)15595-5
-
Peiris, J. S., et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617-619, doi: 10.1016/S0140-6736(04)15595-5 (2004).
-
(2004)
Lancet
, vol.363
, pp. 617-619
-
-
Peiris, J.S.1
-
52
-
-
0037038866
-
Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: A mechanism for the unusual severity of human disease?
-
Cheung, C. Y., et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 360, 1831-1837 (2002).
-
(2002)
Lancet
, vol.360
, pp. 1831-1837
-
-
Cheung, C.Y.1
-
53
-
-
43449131547
-
Pathology molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans
-
doi: 10.2353/ajpath.2008.070791
-
Korteweg, C., & Gu, J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 172, 1155-1170, doi: 10.2353/ajpath.2008.070791 (2008).
-
(2008)
Am J Pathol
, vol.172
, pp. 1155-1170
-
-
Korteweg, C.1
Gu, J.2
-
54
-
-
84890378712
-
Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus
-
doi: 10.1016/j.ajpath.2013.10.004
-
Ogiwara, H., et al. Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus. Am J Pathol 184, 171-183, doi: 10.1016/j.ajpath.2013.10.004 (2014).
-
(2014)
Am J Pathol
, vol.184
, pp. 171-183
-
-
Ogiwara, H.1
-
55
-
-
84919794244
-
Characterization of susceptibility variants of influenza virus grown in the presence of T-705
-
Daikoku, T., Yoshida, Y., Okuda, T., & Shiraki, K. Characterization of susceptibility variants of influenza virus grown in the presence of T-705. Journal of pharmacological sciences 126, 281-284 (2014).
-
(2014)
Journal of Pharmacological Sciences
, vol.126
, pp. 281-284
-
-
Daikoku, T.1
Yoshida, Y.2
Okuda, T.3
Shiraki, K.4
-
56
-
-
84880006467
-
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-Triphosphate towards influenza A virus polymerase
-
doi: 10.1371/journal. pone.0068347
-
Jin, Z., Smith, L. K., Rajwanshi, V. K., Kim, B., & Deval, J. The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-Triphosphate towards influenza A virus polymerase. PloS one 8, e68347, doi: 10.1371/journal. pone.0068347 (2013).
-
(2013)
PloS One
, vol.8
, pp. e68347
-
-
Jin, Z.1
Smith, L.K.2
Rajwanshi, V.K.3
Kim, B.4
Deval, J.5
-
57
-
-
66149185685
-
Benefits and risks of combination therapy for hepatitis B
-
doi: 10.1002/hep.22921
-
Terrault, N. A. Benefits and risks of combination therapy for hepatitis B. Hepatology 49, S122-128, doi: 10.1002/hep.22921 (2009).
-
(2009)
Hepatology
, vol.49
, pp. S122-S128
-
-
Terrault, N.A.1
-
58
-
-
33745158157
-
A simple method of estimating fifty per cent endpoint
-
Reed, L. J., & Muench, H. A simple method of estimating fifty per cent endpoint. American Journal of Hygine 27, 493-497 (1938).
-
(1938)
American Journal of Hygine
, vol.27
, pp. 493-497
-
-
Reed, L.J.1
Muench, H.2
-
59
-
-
84897133117
-
MOSAIK: A hash-based algorithm for accurate next-generation sequencing short-read mapping
-
doi: 10.1371/journal.pone.0090581
-
Lee, W. P., et al. MOSAIK: a hash-based algorithm for accurate next-generation sequencing short-read mapping. PloS one 9, e90581, doi: 10.1371/journal.pone.0090581 (2014).
-
(2014)
PloS One
, vol.9
, pp. e90581
-
-
Lee, W.P.1
-
60
-
-
84870422798
-
Qualimap: Evaluating next-generation sequencing alignment data
-
doi: 10.1093/bioinformatics/bts503
-
Garcia-Alcalde, F., et al. Qualimap: evaluating next-generation sequencing alignment data. Bioinformatics 28, 2678-2679, doi: 10.1093/bioinformatics/bts503 (2012).
-
(2012)
Bioinformatics
, vol.28
, pp. 2678-2679
-
-
Garcia-Alcalde, F.1
-
61
-
-
84884893391
-
V-Phaser 2: Variant inference for viral populations
-
doi: 10.1186/1471-2164-14-674
-
Yang, X., Charlebois, P., Macalalad, A., Henn, M. R., & Zody, M. C. V-Phaser 2: variant inference for viral populations. BMC Genomics 14, 674, doi: 10.1186/1471-2164-14-674 (2013).
-
(2013)
BMC Genomics
, vol.14
, pp. 674
-
-
Yang, X.1
Charlebois, P.2
Macalalad, A.3
Henn, M.R.4
Zody, M.C.5
-
62
-
-
84971316039
-
DiversiTools: A program to analyze the intra-host variation from their high-Throughput reads
-
URL
-
Orton, R., & Hughes, J. diversiTools: A program to analyze the intra-host variation from their high-Throughput reads. diversiTools, Glasgow, Scotland. URL http://josephhughes.github.io/btctools/(2015).
-
(2015)
DiversiTools, Glasgow, Scotland
-
-
Orton, R.1
Hughes, J.2
|